₹-0.34
(Market cap
₹5 Cr
Recently Viewed
Clear AllMarket cap
₹5 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
-8.9 %
ROCE
-5.9 %
Industry P/E
21.35
EV/EBITDA
-25.3
Debt to Equity
0.9
Book Value
₹8.5
EPS
₹-0.6
Face value
10
Shares outstanding
7,002,200
CFO
₹-4.52 Cr
EBITDA
₹-0.69 Cr
Net Profit
₹-0.69 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Boston Bio Systems
| -9.6 | -20.9 | -30.5 | -3.9 | -- | -- | -- |
|
BSE Finance
| -6.1 | 9.6 | -3.4 | -0.3 | 12.0 | 11.6 | 12.8 |
|
Company
|
2014
|
|---|---|
|
Boston Bio Systems
| 248.1 |
|
BSE Small Cap
| 69.2 |
|
BSE Finance
| 59.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Boston Bio Systems
|
6.6 | 4.6 | 0.7 | -0.4 | -59.0 | -7.2 | -- | 0.8 |
| 394.3 | 1,872.4 | 127.7 | 50.9 | 52.7 | 7 | 36.8 | 1.3 | |
| 314.5 | 28,669.3 | 5,136.6 | 915.2 | 33.0 | 15.3 | 31.3 | 4.7 | |
| 701.1 | 15,650.1 | 1,118.4 | 237.9 | 33.9 | 15.9 | 71.9 | 9.6 | |
| 360.5 | 1,022.8 | 175.5 | 52.5 | 51.5 | 3.9 | 21.4 | 0.8 | |
| 64.2 | 1,797.8 | 659.8 | 93.4 | 21.3 | 8.7 | 19.1 | 1.5 | |
| 71.1 | 1,282.8 | 1,855.5 | 181.6 | 83.6 | 10.8 | 7.1 | 0.8 | |
| 2,804.9 | 11,621.2 | 1,239.8 | 214.7 | 20.6 | 30 | 54.1 | 14.2 | |
| 144.8 | 3,175.2 | 1,293.8 | 285.1 | 37.7 | 11.7 | 11.2 | 1.2 | |
| 65.9 | 1,378.7 | 1,781.6 | 85.9 | 18.0 | 6.8 | 16.3 | 1.1 |
No Review & Analysis are available.
Security and commodity contracts brokerage
Incorporated
1995
Chairman
--
Managing Director
Ghanshyam Dhananjay Gavali
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Boston Bio Systems Ltd is ₹6.57 (BSE) as of 24-Apr-2026 IST. Boston Bio Systems Ltd has given a return of -3.95% in the last 1 years.
Since, TTM earnings of Boston Bio Systems Ltd is negative, P/E ratio is not available.
The P/B ratio of Boston Bio Systems Ltd is 0.77 times as on 24-Apr-2026, a 69 discount to its peers’ median range of 2.51 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.92
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Boston Bio Systems Ltd are Rs 10.95 and Rs 5.13 as of 25-Apr-2026.
Boston Bio Systems Ltd has a market capitalisation of ₹ 5 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Boston Bio Systems Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.